Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,661,596
+$254,635 QoQ
Shares Held
10,577
-4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,738
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Occidental Asset Management, LLC holds $27,487,329 across 9 Drug Manufacturers - General names. ABBV ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,777 | $7,295,844 | |
| 2 | AMGN |
Amgen Inc
|
17,469 | $6,325,874 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
34,701 | $4,384,124 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
10,577 | $2,661,596 | |
| 5 | LLY |
ELI LILLY & Co
|
2,219 | $2,661,535 | |
| 6 | JNJ |
Johnson & Johnson
|
7,491 | $1,902,489 | |
| 7 | NVS |
Novartis AG
|
10,018 | $1,570,020 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,807 | $449,839 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,661,596 | 10,577 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,406,961 | 11,067 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,405,314 | 10,527 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $2,209,817 | 9,544 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,495,911 | 8,059 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,666,522 | 7,954 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,304,851 | 7,343 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,577,865 | 7,990 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,278,338 | 7,453 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,335,885 | 7,336 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $993,202 | 6,409 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $968,293 | 6,496 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $870,086 | 6,458 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $1,007,377 | 6,321 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,029,132 | 6,368 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $518,050 | 3,860 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $572,052 | 3,735 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $583,596 | 3,600 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $473,900 | 3,500 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $377,545 | 3,500 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $394,240 | 3,500 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $378,770 | 3,500 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,618,715 | 15,107 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,257,529 | 14,357 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,404,464 | 14,305 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $991,765 | 13,017 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||